School of Medicine Faculty Inducted into Physician-Scientist Associations

Issue Date: 
June 1, 2015

Five University of Pittsburgh School of Medicine faculty members have been inducted into the Association of American Physicians (AAP) and two have been inducted into the American Society for Clinical Investigation (ASCI). 

Election to AAP is an honor extended to individuals with outstanding credentials in biomedical science and/or translational biomedical research and is limited to 60 inductees per year. An association of the country’s most accomplished physician-scientists, AAP serves as a forum to create and disseminate knowledge and as a source of inspiring role models for upcoming generations of physicians and medical scientists.

Election to ASCI reflects early career accomplishments; new members must be age 50 or younger. ASCI represents physician-scientists who are “at the bedside, at the research bench, and at the blackboard.” As many as 80 new members are elected annually from hundreds of nominations.

“I’m delighted that, with their election to these prestigious societies, our next generation of biomedical scientists is being recognized for significant contributions to science and medicine along with our well-established and well-deserving senior investigators,” said Arthur S. Levine, Pitt’s senior vice chancellor for the health sciences and the John and Gertrude Petersen Dean of Medicine. “These honors reflect our deep commitment to fostering faculty research and clinical excellence.” 

AAP Inductees

J. Timothy GreenamyreJ. Timothy Greenamyre is the Love Family Professor of Neurology, and director of the Pittsburgh Institute for Neurodegenerative Diseases and the American Parkinson Disease Association Advanced Center for Parkinson’s Disease Research at the University of Pittsburgh. His research focuses on the mechanisms that cause nerve cell death in disorders such as Parkinson’s, Huntington’s, and Alzheimer’s diseases. Regarding Parkinson’s disease, he is interested in interactions between environmental toxins (natural or man-made) and genes that increase or decrease an individual’s susceptibility to developing the disease.

Juan C. Celedón

Juan C. Celedón is UPMC Niels Jerne Professor of Pediatrics and chief of pediatric pulmonology, allergy, and immunology at Children’s Hospital of Pittsburgh of UPMC. His research seeks to identify genetic factors and early life environmental exposures that influence the development of asthma and chronic obstructive pulmonary disease, particularly in ethnic underrepresented populations.

Yoel Sadovsky

Yoel Sadovsky is the Elsie Hilliard Hillman Professor of Women’s and Infants’ Health Research and scientific director of the Magee-Womens Research Institute. His research explores fetoplacental development and placental nutrition, injury, and adaptation. 

George K. Michalopoulos is the Maud L. Menten Professor of Experimental Pathology and chair of the Department of Pathology. 

George K. Michalopoulos

His research focuses on new therapies for liver fibrosis and the disease mechanisms in alpha-1 antitrypsin deficiency.


John Kirkwood is the Sandra and Thomas Usher Professor of Melanoma as well as a professor of medicine, dermatology, and translational science. 

John Kirkwood

His research aims to develop new and effective treatment approaches for melanoma. He has received international acclaim for leading a multicenter study, based upon his pioneering work with immunomodulators for melanoma, that provided the first FDA-approved adjuvant therapy for melanoma in 1996.


ASCI Inductees

Pawel KalinskiPawel Kalinski is a professor of surgery and of immunology, School of Medicine; professor of infectious diseases and microbiology, Graduate School of Public Health; and professor of bioengineering at the Swanson School of Engineering; as well as director of the Immunotransplantation Center, Division of Surgical Oncology, University of Pittsburgh Cancer Institute. His research seeks to determine the cellular and molecular background of the interactions between tumors and the immune system. He also aims to develop effective measures to counteract tumor-associated immune dysfunction and promote immune-mediated tumor destruction. 


Jeremy KahnJeremy Kahn is an associate professor of critical care medicine in the School of Medicine and of health policy and management in the Graduate School of Public Health. He is researching the organization, management, and financing of critical care services. He also directs several grants from the National Institutes of Health, examining the effect of Intensive Care Unit organization on the outcome of care for patients’ critical illnesses.